LQDA
Liquidia Corp
Company overview
- Market capitalization
- $6.59B
- Employees
- 216
- Latest publication
- 2026-09-29
About Liquidia Corp
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 171,679,000USD | 132,865,000USD | 92,021,000USD | 54,342,000USD | 8,837,000USD | 3,120,000USD | 2,917,000USD | 4,448,000USD |
| Cost Of Revenue | 11,550,000USD | 12,149,000USD | 7,055,000USD | 3,173,000USD | 1,292,000USD | 1,517,000USD | 1,354,000USD | 1,565,000USD |
| Gross Profit | 160,129,000USD | 120,716,000USD | 84,966,000USD | 51,169,000USD | 7,545,000USD | 1,603,000USD | 1,563,000USD | 2,883,000USD |
| Research Development | 17,184,000USD | 12,274,000USD | 16,943,000USD | 9,346,000USD | 6,021,000USD | 6,966,000USD | 16,475,000USD | 11,890,000USD |
| Selling General Administrative | 57,428,000USD | 46,938,000USD | 48,236,000USD | 40,056,000USD | 38,824,000USD | 30,062,000USD | 21,195,000USD | 20,182,000USD |
| Total Operating Expenses | 74,612,000USD | 59,212,000USD | 65,179,000USD | 49,402,000USD | 45,050,000USD | 37,028,000USD | 37,670,000USD | 32,072,000USD |
| Operating Income | 85,517,000USD | 61,504,000USD | 19,787,000USD | 1,767,000USD | -37,505,000USD | -35,425,000USD | -36,107,000USD | -29,189,000USD |
| Total Other Income Expense Net | -3,820,000USD | -4,722,000USD | -5,232,000USD | -5,300,000USD | -4,074,000USD | -2,942,000USD | -2,262,000USD | 6,034,000USD |
| Interest Income | 2,476,000USD | 1,772,000USD | 1,667,000USD | 1,645,000USD | 1,584,000USD | 1,728,000USD | 2,104,000USD | 1,815,000USD |
| Interest Expense | 6,296,000USD | 6,494,000USD | 6,899,000USD | 6,945,000USD | 5,658,000USD | 4,670,000USD | 4,366,000USD | 2,996,000USD |
| Income Before Tax | 81,697,000USD | 56,782,000USD | 14,555,000USD | -3,533,000USD | -41,579,000USD | -38,367,000USD | -38,369,000USD | -23,155,000USD |
| Income Tax Expense | 6,975,000USD | 3,920,000USD | — | — | — | — | — | — |
| Net Income | 74,722,000USD | 52,862,000USD | 14,555,000USD | -3,533,000USD | -41,579,000USD | -38,367,000USD | -38,369,000USD | -23,155,000USD |
| Net Interest Income | — | -4,722,000USD | -5,232,000USD | -5,300,000USD | -4,074,000USD | -2,942,000USD | -2,262,000USD | -1,181,000USD |
| Tax Provision | — | 3,920,000USD | — | — | — | 0USD | — | — |
| Net Income From Continuing Ops | — | 52,862,000USD | 14,555,000USD | -3,533,000USD | -41,579,000USD | -38,367,000USD | -38,369,000USD | -23,155,000USD |
| Ebit | — | 61,504,000USD | 21,454,000USD | 3,412,000USD | -35,921,000USD | -33,697,000USD | -34,003,000USD | -20,159,000USD |
| Ebitda | — | 62,001,000USD | 21,774,000USD | 3,888,000USD | -35,640,000USD | -33,246,000USD | -33,485,000USD | -19,549,000USD |
| Depreciation And Amortization | — | 497,000USD | 320,000USD | 476,000USD | 281,000USD | 451,000USD | 518,000USD | 610,000USD |
| Reconciled Depreciation | — | 497,000USD | 320,000USD | 476,000USD | 281,000USD | 451,000USD | 518,000USD | 610,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 158,320,000USD | 13,996,000USD | 17,488,000USD | 15,935,000USD | 12,853,000USD | 739,628USD | 8,072,120USD | 2,706,981USD |
| Cost Of Revenue | 13,242,000USD | 5,879,000USD | 2,888,000USD | 2,859,000USD | 3,023,000USD | 237,712USD | 807,192USD | 121,391USD |
| Gross Profit | 145,078,000USD | 8,117,000USD | 14,600,000USD | 13,076,000USD | 9,830,000USD | 501,916USD | 7,264,928USD | 2,585,590USD |
| Research Development | 39,276,000USD | 47,842,000USD | 43,242,000USD | 19,435,000USD | 20,517,000USD | 32,222,393USD | 40,491,358USD | 28,699,576USD |
| Selling General Administrative | 157,178,000USD | 81,569,000USD | 44,742,000USD | 32,411,000USD | 23,110,000USD | 27,368,653USD | 13,597,119USD | 8,754,088USD |
| Total Operating Expenses | 196,454,000USD | 129,411,000USD | 87,984,000USD | 51,846,000USD | 43,627,000USD | 59,591,046USD | 54,088,477USD | 37,453,664USD |
| Operating Income | -51,376,000USD | -121,294,000USD | -73,384,000USD | -38,770,000USD | -33,797,000USD | -59,089,130USD | -46,823,549USD | -34,868,074USD |
| Interest Income | 6,624,000USD | 7,654,000USD | 3,180,000USD | 1,090,000USD | 33,435USD | 184,359USD | 613,716USD | 304,981USD |
| Interest Expense | 24,172,000USD | 12,486,000USD | 6,273,000USD | 2,338,000USD | 762,000USD | 857,998USD | 1,373,622USD | 18,988,176USD |
| Net Interest Income | -17,548,000USD | -4,832,000USD | -1,829,000USD | -1,248,000USD | -781,605USD | -673,639USD | -759,906USD | -18,683,195USD |
| Income Before Tax | -68,924,000USD | -130,394,000USD | -78,502,000USD | -41,015,000USD | -34,579,000USD | -59,762,769USD | -47,583,455USD | -53,135,859USD |
| Net Income | -68,924,000USD | -130,394,000USD | -78,502,000USD | -41,015,000USD | -34,579,000USD | -59,762,769USD | -47,583,455USD | -53,135,859USD |
| Net Income From Continuing Ops | -68,924,000USD | -130,394,000USD | -57,585,000USD | -41,015,000USD | -34,578,648USD | -59,762,769USD | -47,583,455USD | -53,135,859USD |
| Ebit | -44,752,000USD | -117,908,000USD | -72,229,000USD | -38,677,000USD | -33,817,000USD | -58,904,771USD | -46,209,833USD | -34,147,683USD |
| Ebitda | -43,224,000USD | -115,711,000USD | -70,051,000USD | -35,030,000USD | -28,205,000USD | -55,788,598USD | -43,416,554USD | -32,604,016USD |
| Depreciation And Amortization | 1,528,000USD | 2,197,000USD | 2,178,000USD | 3,647,000USD | 5,612,000USD | 3,116,173USD | 2,793,279USD | 1,543,667USD |
| Reconciled Depreciation | 1,528,000USD | 2,197,000USD | 2,238,000USD | 3,647,000USD | 5,611,879USD | 3,129,579USD | 2,567,742USD | 1,543,667USD |
| Total Other Income Expense Net | -17,548,000USD | -9,100,000USD | -5,118,000USD | -2,245,000USD | -782,000USD | -673,639USD | -759,906USD | -18,267,785USD |
| Selling And Marketing Expenses | — | — | 780,000USD | — | — | — | — | — |
| Income Tax Expense | — | — | -2,178,000USD | -2,650,000USD | -4,796,839USD | -2,271,581USD | -1,194,120USD | 720,391USD |
| Net Income Applicable To Common Shares | — | — | — | -41,015,000USD | -34,578,648USD | -59,762,769USD | -47,583,455USD | -53,135,859USD |
| Non Operating Income Net Other | — | — | — | — | — | — | 613,716USD | 720,391USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 521,918,000USD | 401,533,000USD | 327,934,000USD | 275,981,000USD | 257,410,000USD | 227,429,000USD | 230,313,000USD | 252,886,000USD |
| Cash And Equivalents | 284,181,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 437,708,000USD | 333,055,000USD | 190,680,000USD | 226,719,000USD | 195,583,000USD | 177,205,000USD | 185,105,000USD | 214,212,000USD |
| Other Current Assets | 8,766,000USD | 7,606,000USD | -54,093,000USD | 8,730,000USD | 5,749,000USD | 4,851,000USD | 5,666,000USD | 5,604,000USD |
| Other Non Current Assets | 19,305,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 326,804,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 189,298,000USD | 149,740,000USD | 135,768,000USD | 102,942,000USD | 78,410,000USD | 60,518,000USD | 41,781,000USD | 33,838,000USD |
| Total Stockholder Equity | 195,114,000USD | 108,579,000USD | 44,748,000USD | 22,052,000USD | 15,188,000USD | 49,713,000USD | 77,275,000USD | 110,518,000USD |
| Total Equity Including Noncontrolling Interest | 195,114,000USD | — | — | — | — | — | — | — |
| Net Receivables | 108,584,000USD | 74,157,000USD | 54,093,000USD | 35,959,000USD | 9,968,000USD | 1,247,000USD | 2,719,000USD | 4,202,000USD |
| Inventory | 36,177,000USD | 28,506,000USD | 23,802,000USD | 24,534,000USD | 6,444,000USD | 1,349,000USD | 241,000USD | 38,000USD |
| Property Plant Equipment Net | 38,620,000USD | 25,196,000USD | 15,793,000USD | 14,718,000USD | 13,615,000USD | 12,616,000USD | 12,485,000USD | 9,155,000USD |
| Goodwill | 3,903,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 2,845,000USD | 2,887,000USD | 2,952,000USD | 2,988,000USD | 3,052,000USD | 3,108,000USD | 3,156,000USD | 3,219,000USD |
| Accounts Payable | 12,748,000USD | 10,981,000USD | 3,678,000USD | 6,019,000USD | 11,346,000USD | 8,675,000USD | 4,689,000USD | 2,298,000USD |
| Common Stock | 89,000USD | 88,000USD | 87,000USD | 87,000USD | 85,000USD | 85,000USD | 85,000USD | 85,000USD |
| Retained Earnings | -498,729,000USD | -573,451,000USD | -626,313,000USD | -640,868,000USD | -637,335,000USD | -595,756,000USD | -559,492,000USD | -521,123,000USD |
| Total Liab | — | 292,954,000USD | 283,186,000USD | 253,929,000USD | 242,222,000USD | 177,716,000USD | 153,038,000USD | 142,368,000USD |
| Other Current Liab | — | 87,729,000USD | 73,197,000USD | 40,016,000USD | 22,522,000USD | 13,841,000USD | 18,659,000USD | 30,291,000USD |
| Capital Stock | — | 88,000USD | 87,000USD | 87,000USD | 85,000USD | 85,000USD | 85,000USD | 85,000USD |
| Good Will | — | 3,903,000USD | 3,903,000USD | 3,903,000USD | 3,903,000USD | 3,903,000USD | 3,903,000USD | 3,903,000USD |
| Other Assets | — | 178,747,000USD | — | — | — | — | — | — |
| Cash | — | 222,786,000USD | 190,680,000USD | 157,496,000USD | 173,422,000USD | 169,758,000USD | 176,479,000USD | 204,368,000USD |
| Cash And Short Term Investments | — | 222,786,000USD | 190,680,000USD | 157,496,000USD | 173,422,000USD | 169,758,000USD | 176,479,000USD | 204,368,000USD |
| Net Debt | — | -37,962,000USD | 7,247,000USD | 41,686,000USD | 26,961,000USD | -22,093,000USD | -54,089,000USD | -201,677,000USD |
| Short Term Debt | — | 51,030,000USD | 58,893,000USD | 56,907,000USD | 44,542,000USD | 38,002,000USD | 18,433,000USD | 1,249,000USD |
| Short Long Term Debt | — | 50,223,000USD | 58,406,000USD | 56,051,000USD | 44,140,000USD | 37,625,000USD | 18,016,000USD | — |
| Short Long Term Debt Total | — | 184,824,000USD | 197,927,000USD | 199,182,000USD | 200,383,000USD | 147,665,000USD | 122,390,000USD | 2,691,000USD |
| Long Term Debt | — | 127,643,000USD | 132,935,000USD | 136,446,000USD | 149,470,000USD | 103,182,000USD | 97,371,000USD | — |
| Property Plant Equipment Gross | — | 42,844,000USD | 29,761,000USD | 31,544,000USD | 30,037,000USD | 28,720,000USD | 28,294,000USD | 25,089,000USD |
| Common Stock Shares Outstanding | — | 101,112,095shares | 100,051,780shares | 86,333,772shares | 85,588,108shares | 85,172,696shares | 84,683,063shares | 78,316,820shares |
| Non Current Assets Total | — | 68,478,000USD | 137,254,000USD | 49,262,000USD | 61,827,000USD | 50,224,000USD | 45,208,000USD | 38,674,000USD |
| Non Current Liabilities Total | — | 143,214,000USD | 147,418,000USD | 150,987,000USD | 163,812,000USD | 117,198,000USD | 111,257,000USD | 108,530,000USD |
| Non Currrent Assets Other | — | 32,115,000USD | 126,895,000USD | 24,149,000USD | 37,753,000USD | 30,597,000USD | 25,664,000USD | 22,397,000USD |
| Net Working Capital | — | 183,315,000USD | 137,633,000USD | 123,777,000USD | 117,173,000USD | 116,687,000USD | 143,324,000USD | 180,374,000USD |
| Unclassified Non Current Assets | — | -174,370,000USD | -12,289,000USD | 3,504,000USD | 3,504,000USD | — | — | — |
| Unclassified Current Liabilities | — | -50,223,000USD | -58,406,000USD | -56,051,000USD | -44,140,000USD | -37,625,000USD | -18,016,000USD | — |
| Unclassified Non Current Liabilities | — | 15,571,000USD | 14,483,000USD | 14,541,000USD | 14,341,000USD | 14,016,000USD | 13,886,000USD | 108,530,000USD |
| Unclassified Equity | — | 681,854,000USD | 670,887,000USD | 662,746,000USD | 652,353,000USD | 645,299,000USD | 636,597,000USD | 631,471,000USD |
| Unclassified Current Assets | — | — | -77,895,000USD | — | — | — | — | — |
| Non Current Liabilities Other | — | — | — | — | 1,000USD | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 327,934,000USD | 230,313,000USD | 118,332,000USD | 129,198,000USD | 93,729,000USD | 99,531,760USD | 68,842,067USD | 49,418,258USD |
| Intangible Assets | 2,952,000USD | 3,156,000USD | 3,430,000USD | 3,726,000USD | 4,390,000USD | 5,534,843USD | — | — |
| Other Current Assets | -54,093,000USD | 5,666,000USD | 2,159,000USD | 1,511,000USD | 792,000USD | 752,447USD | 590,251USD | 219,057USD |
| Total Liab | 283,186,000USD | 153,038,000USD | 71,039,000USD | 38,776,000USD | 28,464,000USD | 28,445,922USD | 33,894,520USD | 30,730,587USD |
| Total Stockholder Equity | 44,748,000USD | 77,275,000USD | 47,293,000USD | 90,422,000USD | 65,265,000USD | 71,085,838USD | 34,947,547USD | 18,687,671USD |
| Other Current Liab | 73,197,000USD | 18,659,000USD | 13,400,000USD | 5,522,000USD | 5,171,000USD | 6,415,259USD | 5,980,019USD | -8,067,676,700USD |
| Common Stock | 87,000USD | 85,000USD | 69,000USD | 64,000USD | 52,000USD | 43,336USD | 28,231USD | 15,520USD |
| Capital Stock | 87,000USD | 85,000USD | 69,000USD | 64,000USD | 52,288USD | 43,336USD | 28,231USD | 15,520USD |
| Retained Earnings | -626,313,000USD | -559,492,000USD | -429,098,000USD | -350,596,000USD | -309,581,000USD | -275,002,219USD | -215,239,450USD | -167,053,897USD |
| Good Will | 3,903,000USD | 3,903,000USD | 3,903,000USD | 3,903,000USD | 3,903,000USD | 3,903,282USD | — | — |
| Cash | 190,680,000USD | 176,479,000USD | 83,679,000USD | 93,283,000USD | 57,494,000USD | 65,316,481USD | 55,796,378USD | 39,534,985USD |
| Cash And Short Term Investments | 190,680,000USD | 176,479,000USD | 83,679,000USD | 93,283,000USD | 57,494,000USD | 65,316,481USD | 55,796,378USD | 39,534,985USD |
| Total Current Assets | 190,680,000USD | 185,105,000USD | 89,899,000USD | 99,811,000USD | 61,276,000USD | 66,068,928USD | 56,386,629USD | 40,026,599USD |
| Total Current Liabilities | 135,768,000USD | 41,781,000USD | 18,550,000USD | 8,800,000USD | 7,327,000USD | 11,737,374USD | 16,874,318USD | 8,248,858USD |
| Net Debt | 7,247,000USD | -54,089,000USD | -34,143,000USD | -68,820,000USD | -41,414,000USD | -48,174,405USD | -31,379,920USD | -26,761,651USD |
| Short Term Debt | 58,893,000USD | 18,433,000USD | 3,754,000USD | 1,081,000USD | 1,086,000USD | 1,587,888USD | 7,396,256USD | 769,609USD |
| Short Long Term Debt | 58,406,000USD | 18,016,000USD | 2,615,000USD | — | — | — | 5,585,637USD | 316,906USD |
| Short Long Term Debt Total | 197,927,000USD | 122,390,000USD | 49,536,000USD | 24,463,000USD | 16,080,000USD | 17,142,076USD | 24,416,458USD | 12,773,339USD |
| Long Term Debt | 132,935,000USD | 97,371,000USD | 43,418,000USD | 19,879,000USD | 10,409,950USD | 10,292,485USD | 10,292,484USD | 11,627,643USD |
| Net Receivables | 54,093,000USD | 2,719,000USD | 4,061,000USD | 5,017,000USD | 2,990,000USD | 0USD | — | 272,557USD |
| Inventory | 23,802,000USD | 241,000USD | 1USD | — | — | — | — | 1USD |
| Accounts Payable | 3,678,000USD | 4,689,000USD | 1,396,000USD | 2,197,000USD | 1,070,000USD | 3,734,227USD | 3,498,043USD | 3,235,949USD |
| Property Plant Equipment Net | 15,793,000USD | 12,485,000USD | 6,184,000USD | 6,252,000USD | 7,429,000USD | 9,454,898USD | 12,077,395USD | 8,130,708USD |
| Property Plant Equipment Gross | 29,761,000USD | 28,294,000USD | 21,498,000USD | 20,366,000USD | 21,012,490USD | 6,805,570USD | 12,077,395USD | 8,130,708USD |
| Common Stock Shares Outstanding | 86,059,101shares | 78,707,503shares | 64,993,476shares | 60,958,862shares | 49,677,737shares | 33,888,434shares | 18,482,455shares | 7,163,304shares |
| Non Current Assets Total | 137,254,000USD | 45,208,000USD | 28,433,000USD | 29,387,000USD | 32,453,000USD | 33,462,832USD | 12,455,438USD | 9,391,659USD |
| Non Current Liabilities Total | 147,418,000USD | 111,257,000USD | 52,489,000USD | 29,976,000USD | 21,137,000USD | 16,708,548USD | 17,020,202USD | 22,481,729USD |
| Non Currrent Assets Other | 126,895,000USD | 25,664,000USD | 14,916,000USD | 15,506,000USD | 16,731,000USD | 14,569,809USD | 378,043USD | 1,260,951USD |
| Net Working Capital | 137,633,000USD | 143,324,000USD | 71,349,000USD | 91,011,000USD | 53,949,236USD | 54,331,554USD | 39,512,311USD | 31,777,741USD |
| Unclassified Current Assets | -77,895,000USD | — | — | — | — | — | — | — |
| Unclassified Non Current Assets | -12,289,000USD | — | — | -129,198,000USD | -16,730,811USD | -17,219,137USD | — | -1,260,951USD |
| Unclassified Current Liabilities | -58,406,000USD | -18,016,000USD | -2,615,000USD | — | — | -4,646,395USD | -5,585,637USD | -8,067,993,606USD |
| Unclassified Non Current Liabilities | 14,483,000USD | 13,886,000USD | 9,071,000USD | -5,101,000USD | -5,554,892USD | -7,530,788USD | 6,727,718USD | -8,613,395USD |
| Unclassified Equity | 670,887,000USD | 636,597,000USD | 476,253,000USD | 440,890,000USD | 374,741,712USD | 346,001,385USD | 261,463,647USD | 195,015,250USD |
| Other Assets | — | — | 1USD | 129,198,000USD | 16,730,811USD | 17,219,137USD | 378,043USD | 1,260,951USD |
| Deferred Long Term Liab | — | — | — | 8,604,000USD | 10,138,434USD | 12,792,491USD | — | 917,557USD |
| Other Liab | — | — | — | 6,594,000USD | 6,143,508USD | 1,154,360USD | — | 10,478,004USD |
| Net Tangible Assets | — | — | — | 82,793,000USD | 56,972,583USD | 61,647,713USD | 34,947,547USD | 18,687,671USD |
| Current Deferred Revenue | — | — | — | — | — | 4,646,395USD | — | 8,071,920,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | 0USD | -11,333,112USD | -9,304,722USD |
| Non Current Liabilities Other | — | — | — | — | — | — | — | 8,071,920USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 897,000USD |
| Stock Based Compensation | 19,587,000USD |
| Change To Inventory | -12,061,000USD |
| Change To Liabilities | 325,000USD |
| Change In Working Capital | 24,864,000USD |
| Operating Cash Flow | 133,234,000USD |
| Capital Expenditures | -14,065,000USD |
| Unclassified Investing Cash Flow | -1,000,000USD |
| Investing Cash Flow | -15,065,000USD |
| Net Debt Issuance | -28,026,000USD |
| Common Stock Issuance | 3,195,000USD |
| Unclassified Financing Cash Flow | 163,000USD |
| Financing Cash Flow | -24,668,000USD |
| Change In Cash | 93,501,000USD |
| End Cash Flow | 287,685,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 52,862,000USD | 14,555,000USD | -3,533,000USD | -41,579,000USD | -38,367,000USD | -38,369,000USD | -23,155,000USD | -27,942,000USD |
| Depreciation | 497,000USD | 321,000USD | 476,000USD | 281,000USD | 451,000USD | 518,000USD | 610,000USD | 580,000USD |
| Stock Based Compensation | 9,217,000USD | 7,206,000USD | 7,898,000USD | 6,930,000USD | 7,438,000USD | 5,029,000USD | 4,881,000USD | 4,372,000USD |
| Other Non Cash Items | 6,085,000USD | 8,976,000USD | 7,005,000USD | 5,714,000USD | 4,725,000USD | 8,015,000USD | -7,538,000USD | 2,718,000USD |
| Change To Account Receivables | -20,064,000USD | -18,134,000USD | -25,991,000USD | -8,721,000USD | 1,472,000USD | 1,483,000USD | -953,000USD | -679,000USD |
| Change To Inventory | -4,565,000USD | 943,000USD | -17,951,000USD | -4,872,000USD | -1,108,000USD | -203,000USD | 7,174,000USD | -3,695,000USD |
| Change In Working Capital | -15,671,000USD | 13,186,000USD | -21,616,000USD | -10,827,000USD | -4,926,000USD | 3,994,000USD | 120,000USD | -2,389,000USD |
| Total Cash From Operating Activities | 52,990,000USD | 44,244,000USD | -9,770,000USD | -39,481,000USD | -30,679,000USD | -20,813,000USD | -25,082,000USD | -22,661,000USD |
| Capital Expenditures | -2,830,000USD | -2,038,000USD | -911,000USD | -1,057,000USD | -330,000USD | -4,788,000USD | -1,747,000USD | -1,290,000USD |
| Free Cash Flow | 50,160,000USD | 42,206,000USD | -10,681,000USD | -40,538,000USD | -31,009,000USD | -25,601,000USD | -26,829,000USD | -23,951,000USD |
| Total Cashflows From Investing Activities | -2,830,000USD | -4,038,000USD | -911,000USD | -1,057,000USD | -330,000USD | -4,780,000USD | -1,747,000USD | -1,290,000USD |
| Net Borrowings | -19,969,000USD | -8,057,000USD | -8,057,000USD | 47,146,000USD | 22,789,000USD | -4,880,000USD | 31,419,000USD | — |
| Total Cash From Financing Activities | -18,054,000USD | -7,022,000USD | -5,245,000USD | 47,706,000USD | 24,288,000USD | -2,296,000USD | 98,104,000USD | -814,000USD |
| Change In Cash | 32,106,000USD | 33,184,000USD | -15,926,000USD | 7,168,000USD | -6,721,000USD | -27,889,000USD | 71,275,000USD | -24,765,000USD |
| Begin Period Cash Flow | 194,184,000USD | 157,496,000USD | 176,926,000USD | 169,758,000USD | 176,479,000USD | 204,368,000USD | 133,093,000USD | 157,858,000USD |
| End Period Cash Flow | 226,290,000USD | 190,680,000USD | 161,000,000USD | 176,926,000USD | 169,758,000USD | 176,479,000USD | 204,368,000USD | 133,093,000USD |
| Other Cashflows From Financing Activities | 163,000USD | 100,000USD | 314,000USD | 435,000USD | 235,000USD | 2,926,000USD | 1,621,000USD | -819,000USD |
| Unclassified Financing Cash Flow | 1,752,000USD | — | 2,498,000USD | — | 1,264,000USD | — | 1,039,000USD | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | -342,000USD | 64,025,000USD | 0USD |
| Other Cashflows From Investing Activities | — | -2,000,000USD | — | — | — | -3,492,000USD | — | — |
| Investments | — | — | -911,000USD | -1,057,000USD | -330,000USD | -4,780,000USD | -1,747,000USD | -1,290,000USD |
| Unclassified Investing Cash Flow | — | — | — | 1,057,000USD | — | 8,280,000USD | 1,747,000USD | 1,290,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -68,924,000USD | -130,394,000USD | -78,502,000USD | -41,015,000USD | -34,579,000USD | -59,762,769USD | -47,583,455USD | -53,135,859USD |
| Depreciation | 1,528,000USD | 2,197,000USD | 2,178,000USD | 3,647,000USD | 5,612,000USD | 3,129,579USD | 2,567,742USD | 1,543,667USD |
| Stock Based Compensation | 29,472,000USD | 18,806,000USD | 10,089,000USD | 9,298,000USD | 6,746,000USD | 3,954,000USD | 3,376,305USD | 2,195,075USD |
| Other Non Cash Items | 26,421,000USD | 20,761,000USD | 18,799,000USD | 1,640,000USD | 566,000USD | 235,526USD | 300,901USD | 17,687,146USD |
| Change To Account Receivables | -51,374,000USD | 1,342,000USD | 956,000USD | -2,027,000USD | -2,990,000USD | -2,989,717USD | 272,557USD | 1,349,622,000USD |
| Change To Inventory | -22,988,000USD | -241,000USD | 0USD | — | -1,730,154USD | — | -272,557USD | -1,346,987,000USD |
| Change In Working Capital | -24,183,000USD | -4,792,000USD | 5,872,000USD | -2,158,000USD | -12,380,000USD | -1,711,645USD | -6,950,754USD | 294,846USD |
| Total Cash From Operating Activities | -35,686,000USD | -93,422,000USD | -41,564,000USD | -28,588,000USD | -34,035,000USD | -54,144,507USD | -48,282,674USD | -31,830,535USD |
| Capital Expenditures | -4,336,000USD | -4,949,000USD | -1,290,000USD | -592,000USD | -107,000USD | -752,086USD | -1,850,099USD | -870,943USD |
| Free Cash Flow | -40,022,000USD | -98,371,000USD | -42,854,000USD | -29,180,000USD | -34,142,000USD | -54,896,593USD | -50,132,773USD | -32,701,478USD |
| Total Cashflows From Investing Activities | -6,336,000USD | -8,441,000USD | -11,288,000USD | -587,000USD | -107,000USD | 247,914USD | -1,850,099USD | -870,943USD |
| Net Borrowings | 53,821,000USD | 52,500,000USD | 17,719,000USD | 8,956,000USD | -419,841USD | -6,769,416USD | 4,001,313USD | -1,425,275USD |
| Total Cash From Financing Activities | 59,727,000USD | 194,663,000USD | 43,248,000USD | 64,964,000USD | 26,320,000USD | 63,416,696USD | 66,394,166USD | 68,817,484USD |
| Issuance Of Capital Stock | 0USD | 138,551,000USD | 24,238,000USD | 54,461,000USD | 21,709,949USD | 71,225,398USD | 63,039,490USD | 72,427,129USD |
| Change In Cash | 14,201,000USD | 92,800,000USD | -9,604,000USD | 35,789,000USD | -7,822,000USD | 9,520,103USD | 16,261,393USD | 36,116,006USD |
| Begin Period Cash Flow | 176,479,000USD | 83,679,000USD | 93,283,000USD | 57,494,000USD | 65,316,000USD | 55,796,378USD | 39,534,985USD | 3,418,979USD |
| End Period Cash Flow | 190,680,000USD | 176,479,000USD | 83,679,000USD | 93,283,000USD | 57,494,000USD | 65,316,481USD | 55,796,378USD | 39,534,985USD |
| Other Cashflows From Investing Activities | -2,000,000USD | -3,492,000USD | -9,998,000USD | 5,000USD | — | — | -1,850,000USD | — |
| Other Cashflows From Financing Activities | 1,084,000USD | 3,612,000USD | -363,000USD | 1,547,000USD | 5,030,000USD | -1,039,286USD | -611,988USD | 22,922,526USD |
| Unclassified Financing Cash Flow | 4,822,000USD | — | 1,654,000USD | — | — | — | — | -25,442,427USD |
| Investments | — | -8,441,000USD | -11,573,000USD | -587,000USD | -107,220USD | 247,914USD | -1,850,099USD | -870,943USD |
| Unclassified Investing Cash Flow | — | 8,441,000USD | 11,573,000USD | — | — | — | 3,700,099USD | — |
| Change To Liabilities | — | — | — | 814,000USD | -7,558,844USD | -297,160USD | 834,975USD | -2,903,168USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 62,427,502USD | 72,762,660USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | — | 16,261,393USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 129,881,000 | USD | 0001104659-26-058252 |
| Q1 2026Quarterly · 2026-03-31 | Product | Services | 2,984,000 | USD | 0001104659-26-058252 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 148,288,000 | USD | 0001104659-26-023804 |
| FY 2025Yearly · 2025-12-31 | Product | Services | 10,032,000 | USD | 0001104659-26-023804 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 51,669,000 | USD | 0001104659-25-105215 |
| Q3 2025Quarterly · 2025-09-30 | Product | Services | 2,673,000 | USD | 0001104659-25-105215 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 6,517,000 | USD | 0001558370-25-011139 |
| Q2 2025Quarterly · 2025-06-30 | Product | Services | 2,320,000 | USD | 0001558370-25-011139 |
| FY 2020Yearly · 2020-12-31 | Product | Collaboration | 0 | USD | 0001437749-21-007174 |
| FY 2020Yearly · 2020-12-31 | Product | Nonrefundable Payments Milestones | 0 | USD | 0001437749-21-007174 |
| FY 2020Yearly · 2020-12-31 | Product | Nonrefundable Payments Upfront Payments | 0 | USD | 0001437749-21-007174 |
| FY 2020Yearly · 2020-12-31 | Product | Promotion Agreement | 739,628 | USD | 0001437749-21-007174 |
| FY 2020Yearly · 2020-12-31 | Product | Research And Development Services | 0 | USD | 0001437749-21-007174 |
| FY 2020Yearly · 2020-12-31 | Product | Royalty | 0 | USD | 0001437749-21-007174 |
| FY 2019Yearly · 2019-12-31 | Product | Collaboration — Nonrefundable Payments Milestones | 1,345,320 | USD | 0001437749-21-007174 |
| FY 2019Yearly · 2019-12-31 | Product | Collaboration — Nonrefundable Payments Upfront Payments | 6,726,600 | USD | 0001437749-21-007174 |
| FY 2019Yearly · 2019-12-31 | Product | Other | 27,880 | USD | 0001437749-21-007174 |
| FY 2019Yearly · 2019-12-31 | Product | Promotion Agreement | 0 | USD | 0001437749-21-007174 |
| FY 2019Yearly · 2019-12-31 | Product | Research And Development Services | 200 | USD | 0001437749-21-007174 |
| FY 2019Yearly · 2019-12-31 | Product | Royalty | 0 | USD | 0001437749-21-007174 |
| FY 2019Yearly · 2019-12-31 | Product | Services | 0 | USD | 0001437749-21-007174 |
| Q2 2019Quarterly · 2019-06-30 | Product | Collaboration And Licensing Milestones | 1,345,320 | USD | 0001558370-19-008123 |
| Q2 2019Quarterly · 2019-06-30 | Product | Collaboration And Licensing Non Refundable Upfront Payments | 6,726,600 | USD | 0001558370-19-008123 |
| Q2 2019Quarterly · 2019-06-30 | Product | Research And Development Services | 200 | USD | 0001558370-19-008123 |
| FY 2018Yearly · 2018-12-31 | Product | Nonrefundable Payments Milestones | 45,058 | USD | 0001437749-20-005249 |
| FY 2018Yearly · 2018-12-31 | Product | Nonrefundable Payments Upfront Payments | 1,168,712 | USD | 0001437749-20-005249 |
| FY 2018Yearly · 2018-12-31 | Product | Research And Development Services | 1,493,211 | USD | 0001437749-20-005249 |
| Q2 2018Quarterly · 2018-06-30 | Product | Collaboration And Licensing Non Refundable Upfront Payments | 943,419 | USD | 0001558370-19-008123 |
| Q2 2018Quarterly · 2018-06-30 | Product | Research And Development Services | 99,460 | USD | 0001558370-19-008123 |
| Q1 2018Quarterly · 2018-03-31 | Product | Collaboration And Licensing Milestones | 45,058 | USD | 0001558370-19-003810 |
| Q1 2018Quarterly · 2018-03-31 | Product | Collaboration And Licensing Non Refundable Upfront Payments | 225,293 | USD | 0001558370-19-003810 |
| Q1 2018Quarterly · 2018-03-31 | Product | Research And Development Services | 655,619 | USD | 0001558370-19-003810 |
| FY 2017Yearly · 2017-12-31 | Product | Collaboration And Licensing Non Refundable Upfront Payments | 3,343,216 | USD | 0001558370-19-001047 |
| FY 2017Yearly · 2017-12-31 | Product | Research And Development Services | 3,914,907 | USD | 0001558370-19-001047 |
| Q3 2017Quarterly · 2017-09-30 | Product | Collaboration And Licensing Non Refundable Upfront Payments | 835,804 | USD | 0001558370-18-008141 |
| Q3 2017Quarterly · 2017-09-30 | Product | Research And Development Services | 985,044 | USD | 0001558370-18-008141 |
| Q2 2017Quarterly · 2017-06-30 | Product | Collaboration And Licensing Non Refundable Upfront Payments | 835,819 | USD | 0001558370-18-007057 |
| Q2 2017Quarterly · 2017-06-30 | Product | Research And Development Services | 1,146,178 | USD | 0001558370-18-007057 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.